124 related articles for article (PubMed ID: 17225027)
1. Lichen aureus induced by interferon-alpha plus ribavirin.
González-Sixto B; García-Doval I; Conde A; Mayo E; Pardavila R; De La Torre C; Cruces M
Acta Derm Venereol; 2007; 87(1):87-8. PubMed ID: 17225027
[No Abstract] [Full Text] [Related]
2. Lichen Aureus associated with interferon-alfa plus ribavirin.
Baraldi C; Dika E; Barisani A; Fanti PA; Patrizi A; Vaccari S
G Ital Dermatol Venereol; 2017 Feb; 152(1):86-88. PubMed ID: 27978614
[No Abstract] [Full Text] [Related]
3. Diffuse cutaneous eruption due to interferon alfa and ribavirin treatment of chronic hepatitis C.
Savk E; Uslu G; Karaoğlu AO; Sendur N; Karaman G
J Eur Acad Dermatol Venereol; 2005 May; 19(3):396-8. PubMed ID: 15857485
[No Abstract] [Full Text] [Related]
4. [Onset of type 1 diabetes mellitus during combination therapy of chronic hepatitis C with interferon-alpha and ribavirin].
Christensen UB; Krogsgaard K
Ugeskr Laeger; 2004 Mar; 166(11):1024-5. PubMed ID: 15049242
[No Abstract] [Full Text] [Related]
5. Interferon plus ribavirin: a cautionary note.
Macedo G; Ribeiro T
Am J Gastroenterol; 1999 Oct; 94(10):3087-8. PubMed ID: 10520894
[No Abstract] [Full Text] [Related]
6. Development of Myasthenia gravis due to treatment of chronic hepatitis C with a combination of interferon-alpha and ribavirin.
Bektas M; Bektas H; Gören D; Altan M; Cetinkaya H
Digestion; 2007; 75(4):208-9. PubMed ID: 17934275
[No Abstract] [Full Text] [Related]
7. Vogt-Koyanagi-Harada disease associated with interferon-A and ribavirin therapy for chronic hepatitis C infection.
Papastathopoulos K; Bouzas E; Naoum G; Vergados I; Tsiodras S
J Infect; 2006 Feb; 52(2):e59-61. PubMed ID: 15951019
[TBL] [Abstract][Full Text] [Related]
8. [Vitiligo and alopecia in patients with chronic hepatitis C treated with alpha interferon associated or not with ribavirin].
Primo J; Merino C; Gómez Belda AB
Gastroenterol Hepatol; 2000; 23(7):362-3. PubMed ID: 11002542
[No Abstract] [Full Text] [Related]
9. Tongue hyperpigmentation during interferon-alpha and ribavirin therapy.
Aguayo-Leiva I; Pérez B; Salguero I; Jaén P
Eur J Dermatol; 2009; 19(3):291-2. PubMed ID: 19286489
[No Abstract] [Full Text] [Related]
10. [Lichenoid eruption in a patient with chronic hepatitis C virus infection treated with interferon and ribavirin].
Guillermo N; Hernández Santana J; Borrego L; Jorge M
Gastroenterol Hepatol; 2009 Feb; 32(2):130-1. PubMed ID: 19231693
[No Abstract] [Full Text] [Related]
11. Interferon-ribavirin-associated ischemic colitis.
Punnam SR; Pothula VR; Gourineni N; Punnam A; Ranganathan V
J Clin Gastroenterol; 2008 Mar; 42(3):323-5. PubMed ID: 18223489
[TBL] [Abstract][Full Text] [Related]
12. Oral lichenoid lesions in HIV-HCV-coinfected subjects during antiviral therapy: 2 cases and review of the literature.
Giuliani M; Lajolo C; Sartorio A; Scivetti M; Capodiferro S; Tumbarello M
Am J Dermatopathol; 2008 Oct; 30(5):466-71. PubMed ID: 18806491
[TBL] [Abstract][Full Text] [Related]
13. Meyerson's phenomenon induced by interferon-alfa plus ribavirin in hepatitis C infection.
Girard C; Bessis D; Blatìre V; Guilhou JJ; Guillot B
Br J Dermatol; 2005 Jan; 152(1):182-3. PubMed ID: 15656829
[No Abstract] [Full Text] [Related]
14. Generalized lichen nitidus with involvement of the palms following interferon alpha treatment.
Scheler M; Proelss J; Bräuninger W; Bieber T; Wenzel J
Dermatology; 2007; 215(3):236-9. PubMed ID: 17823522
[TBL] [Abstract][Full Text] [Related]
15. Concurrent antiphospholipid syndrome and cutaneous [corrected] sarcoidosis due to interferon alfa and ribavirin treatment for hepatitis C.
Shinohara MM; Davis C; Olerud J
J Drugs Dermatol; 2009 Sep; 8(9):870-2. PubMed ID: 19746680
[TBL] [Abstract][Full Text] [Related]
16. Meyerson's naevi induced by interferon alfa plus ribavirin combination therapy in hepatitis C infection.
Conde-Taboada A; de la Torre C; Feal C; Mayo E; Gonzalez-Sixto B; Cruces MJ
Br J Dermatol; 2005 Nov; 153(5):1070-2. PubMed ID: 16225630
[No Abstract] [Full Text] [Related]
17. Interferon-induced haemolytic anaemia in hepatitis C.
Al-Ansari M; Weilert F; Dickson G
N Z Med J; 2008 Jul; 121(1278):78-81. PubMed ID: 18670477
[No Abstract] [Full Text] [Related]
18. [Efficacy of combined antiviral therapy with interferon alfa and ribavirin in chronic hepatitis C patients with extrahepatic manifestations].
Zarebska-Michaluk D; Lebensztejn DM; Kryczka W
Przegl Epidemiol; 2007; 61(3):551-8. PubMed ID: 18069393
[TBL] [Abstract][Full Text] [Related]
19. [Treatment of chronic viral hepatitis].
Pedersen C; Pedersen CR
Ugeskr Laeger; 2008 Jun; 170(24):2137-40. PubMed ID: 18565297
[TBL] [Abstract][Full Text] [Related]
20. Worsening of lichen myxedematosus during interferon alfa-2a therapy for chronic active hepatitis C.
Rongioletti F; Rebora A
J Am Acad Dermatol; 1998 May; 38(5 Pt 1):760-1. PubMed ID: 9591822
[No Abstract] [Full Text] [Related]
[Next] [New Search]
